Ecstasy: Where The Feds Disagree

Since the early '90s, as more and more youths have discovered ecstasy, government scientists have tried to speak with a clear voice that the drug carries life-threatening risks and no benefits. Now that voice has cracked.

The FDA has sanctioned a study of methylenedioxymethamphetamine, better known as MDMA, or ecstasy, as a possible treatment for post-traumatic stress disorder. Once it is approved by a review board at a research facility, the study will mark the first time in three decades that the government has allowed researchers to give a psychedelic drug to subjects who have never taken it, which suggests the...

Want the full story?

Subscribe Now


Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!